Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
暂无分享,去创建一个
T. Yamanaka | H. Saka | K. Goto | K. Takayama | M. Nishio | Toshiaki Takahashi | N. Yamamoto | T. Seto | K. Takeda | H. Yoshioka | H. Kaneda | H. Nokihara | H. Sakai | H. Harada | M. Tachihara | O. Ishimoto
[1] Oecd Indicators. Health at a Glance 2015 , 2015 .
[2] H. Choy,et al. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. , 2013, International journal of radiation oncology, biology, physics.
[3] Andrew Bottomley,et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] R. Fietkau,et al. Prevalence of Brain Metastases Immediately before Prophylactic Cranial Irradiation in Limited Disease Small Cell Lung Cancer Patients with Complete Remission to Chemoradiotherapy: A Single Institution Experience , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] Z. Qing. Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer , 2008 .
[6] N. Saijo,et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702 , 2007, British Journal of Cancer.
[7] A. Twijnstra,et al. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Twijnstra,et al. Asymptomatic Brain Metastases (BM) in Small Cell Lung Cancer (SCLC): MR-imaging is Useful at Initial Diagnosis , 2000, Journal of Neuro-Oncology.
[9] Armin Thron,et al. Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases , 2004, Journal of Neuro-Oncology.
[10] R. Arriagada,et al. Prophylactic cranial irradiation in small cell lung cancer. , 2003, Seminars in oncology.
[11] K. Mori,et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. , 2002, The New England journal of medicine.
[12] J. Verdebout,et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis , 2001, BMC Cancer.
[13] J. Daurès,et al. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent , 2000, British Journal of Cancer.
[14] J P Pignon,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.
[15] J. A. Santos-Miranda,et al. Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. , 1998, Lung cancer.
[16] D. Girling,et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial , 1997 .
[17] P Chomy,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. , 1995, Journal of the National Cancer Institute.
[18] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[19] L C Gatewood,et al. Network analytic methods for epidemiological risk assessment. , 1994, Statistics in medicine.
[20] P. Hudgins,et al. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. , 1991, AJNR. American journal of neuroradiology.
[21] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .